March 13, 2026
1 min read

FDA scolds CDMO Simtra with warning letter over contamination fumbles

Simtra BioPharma Solutions was issued a warning letter by the FDA after an inspection uncovered a number of problems at the CDMO’s production plant in Halle, Germany.

Leave a Reply

Your email address will not be published.

Previous Story

FDA fires off another manufacturing-related CRL, this one to Hyloris

Next Story

FDA move on flavored vapes rattles public health experts

Previous Story

FDA fires off another manufacturing-related CRL, this one to Hyloris

Next Story

FDA move on flavored vapes rattles public health experts

Latest from Blog

Go toTop